Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion

被引：30

作者：

Mullins, Riley D. Z. ^{[1
,2
]}

Pal, Ananya ^{[1
,2
]}

Barrett, Thomas F. ^{[1
,2
]}

Neal, Molly E. Heft ^{[2
]}

Puram, Sidharth V. ^{[1
,2
,3
]}

机构：

[1] Washington Univ, Dept Genet, Sch Med, St Louis, MO USA

[2] Washington Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, St Louis, MO USA

[3] Washington Univ, Otolaryngol Head & Neck Surg, Sch Med, 4515 McKinley Ave, St Louis, MO 63110 USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 13期

关键词：

CANCER STEM-CELLS; MHC CLASS-I; NF-KAPPA-B; E-CADHERIN; GROWTH-FACTOR; MIR-200; FAMILY; TRANSITION; EMT; CARCINOMA; METASTASIS;

D O I：

10.1158/0008-5472.CAN-21-4370

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epithelial-mesenchymal transition (EMT) is a fundamental process that occurs during embryogenesis and tissue repair. How-ever, EMT can be hijacked by malignant cells, where it may promote immune evasion and metastasis. Classically considered a dichoto-mous transition, EMT in cancer has recently been considered a plastic process whereby malignant cells display and interconvert among hybrid epithelial/mesenchymal (E/M) states. Epithelial- mesenchymal plasticity (EMP) and associated hybrid E/M states are divergent from classical EMT, with unique immunomodulatory effects. Here, we review recent insights into the EMP-immune cross -talk, highlighting possible mechanisms of immune evasion con-ferred by hybrid E/M states and roles of immune cells in EMP.

引用

页码：2329 / 2343

页数：15

共 184 条

[31] Transcriptional census of epithelial-mesenchymal plasticity in cancer [J].

Cook, David P. ;

Vanderhyden, Barbara C. .

SCIENCE ADVANCES, 2022, 8 (01)

[32] Context specificity of the EMT transcriptional response [J].

Cook, David P. ;

Vanderhyden, Barbara C. .

NATURE COMMUNICATIONS, 2020, 11 (01)

[33] Cancer stem cells: Models and concepts [J].

Dalerba, Piero ;

Cho, Robert W. ;

Clarke, Michael F. .

ANNUAL REVIEW OF MEDICINE, 2007, 58 :267-284

[34] Contextual determinants of TGFβ action in development, immunity and cancer [J].

David, Charles J. ;

Massague, Joan .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2018, 19 (07) :419-435

[35] The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance [J].

David, Justin M. ;

Dominguez, Charli ;

Hamilton, Duane H. ;

Palena, Claudia .

VACCINES, 2016, 4 (03)

[36] MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition [J].

David, Justin M. ;

Hamilton, Duane H. ;

Palena, Claudia .

ONCOIMMUNOLOGY, 2016, 5 (04)

[37] Regulatory networks defining EMT during cancer initiation and progression [J].

De Craene, Bram ;

Berx, Geert .

NATURE REVIEWS CANCER, 2013, 13 (02) :97-110

[38] Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing [J].

Deshmukh, Abhijeet P. ;

Vasaikar, Suhas V. ;

Tomczak, Katarzyna ;

Tripathi, Shubham ;

den Hollander, Petra ;

Arslan, Emre ;

Chakraborty, Priyanka ;

Soundararajan, Rama ;

Jolly, Mohit Kumar ;

Rai, Kunal ;

Levine, Herbert ;

Mani, Sendurai A. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (19)

[39] Direct and Indirect Regulators of Epithelial-Mesenchymal Transition-Mediated Immunosuppression in Breast Carcinomas [J].

Dongre, Anushka ;

Rashidian, Mohammad ;

Eaton, Elinor Ng ;

Reinhardt, Ferenc ;

Thiru, Prathapan ;

Zagorulya, Maria ;

Nepal, Sunita ;

Banaz, Tuba ;

Martner, Anna ;

Spranger, Stefani ;

Weinberg, Robert A. .

CANCER DISCOVERY, 2021, 11 (05) :1286-1305

[40] New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J].

Dongre, Anushka ;

Weinberg, Robert A. .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) :69-84

← 1 2 3 4 5 6 7 8 9 10 →